Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2010 1
2011 1
2013 1
2015 5
2017 3
2018 7
2019 17
2020 14
2021 17
2022 7
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.
Lum SH, Albert MH, Gilbert P, Sirait T, Algeri M, Muratori R, Fournier B, Laberko A, Karakukcu M, Unal E, Ayas MF, Yadav SP, Fisgin T, Elfeky R, Fernandes JF, Faraci M, Cole T, Schulz AS, Meisel R, Zecca M, Ifversen M, Biffi A, Diana JS, Vallée TC, Giardino S, Ersoy GZ, Moshous D, Gennery AR, Balashov D, Bonfim CMS, Locatelli F, Lankester AC, Neven B, Slatter MA. Lum SH, et al. Among authors: ifversen m. Blood. 2024 Apr 26:blood.2024024038. doi: 10.1182/blood.2024024038. Online ahead of print. Blood. 2024. PMID: 38669631
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation.
Böhm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlmann M, Yacobovich J, Beier R, Speckmann C, Behnisch W, Ifversen M, Jordan M, Marsh R, Naumann-Bartsch N, Mauz-Körholz C, Hönig M, Schulz A, Malinowska I, Hines M, Nichols KE, Gil-Herrera J, Talano JA, Crooks B, Formankova R, Jorch N, Bakhtiar S, Kühnle I, Streiter M, Nathrath M, Russo A, Dürken M, Lang P, Lindemans C, Henter JI, Lehmberg K, Ehl S. Böhm S, et al. Among authors: ifversen m. Blood. 2024 Mar 7;143(10):872-881. doi: 10.1182/blood.2023022281. Blood. 2024. PMID: 37992218
Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.
Cseh A, Galimard JE, de la Fuente J, Isgro A, Zecca M, Garwer B, Biffi A, Aljurf M, Sundin M, Belendez C, Locatelli F, Balduzzi A, Lawson S, Sengeloev H, Ifversen M, Saccardi R, Wynn R, Lankester AC, Corbacioglu S, Peters C. Cseh A, et al. Among authors: ifversen m. Br J Haematol. 2024 Jan;204(1):e1-e5. doi: 10.1111/bjh.19122. Epub 2023 Oct 5. Br J Haematol. 2024. PMID: 37795523
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study.
Bader P, Pötschger U, Dalle JH, Moser LM, Balduzzi A, Ansari M, Buechner J, Güngör T, Ifversen M, Krivan G, Pichler H, Renard M, Staciuk R, Sedlacek P, Stein J, Heusel JR, Truong T, Wachowiak J, Yesilipek A, Locatelli F, Peters C. Bader P, et al. Among authors: ifversen m. Blood Adv. 2024 Jan 23;8(2):416-428. doi: 10.1182/bloodadvances.2023010591. Blood Adv. 2024. PMID: 37738088 Free PMC article. Clinical Trial.
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
Averbuch D, de la Camara R, Tridello G, Knelange NS, Bykova TA, Ifversen M, Dobsinska V, Ayas M, Hamidieh AA, Pichler H, Perez-Martinez A, Cesaro S, Sundin M, Badell I, Bader P, Johansson JE, Mirci-Danicar O, Sedlacek P, Paillard C, Gibson B, Lawson S, Kroeger N, Corbacioglu S, Mikulska M, Piñana JL, Styczynski J, Ljungman P. Averbuch D, et al. Among authors: ifversen m. Bone Marrow Transplant. 2023 May;58(5):558-566. doi: 10.1038/s41409-023-01941-5. Epub 2023 Feb 27. Bone Marrow Transplant. 2023. PMID: 36849806 Free PMC article.
The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation.
Hergel LLF, Kielsen K, Weischendorff S, Ifversen M, Kamari-Kany N, Møller HJ, Rittig S, Grønbæk H, Müller K. Hergel LLF, et al. Among authors: ifversen m. Bone Marrow Transplant. 2023 May;58(5):587-589. doi: 10.1038/s41409-023-01927-3. Epub 2023 Jan 31. Bone Marrow Transplant. 2023. PMID: 36721043 No abstract available.
Plasma Levels of MRP-8/14 Associate With Neutrophil Recovery, Bacterial Bloodstream Infections, and Engraftment Syndrome Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Kammersgaard MB, Kielsen K, Nielsen CH, Ifversen M, Bohr AH, Müller K. Kammersgaard MB, et al. Among authors: ifversen m. Transplant Cell Ther. 2023 Apr;29(4):242.e1-242.e9. doi: 10.1016/j.jtct.2022.12.019. Epub 2022 Dec 30. Transplant Cell Ther. 2023. PMID: 36587741 Free article.
73 results